Harrow IP, LLC

Imprimis Pharmaceuticals, Inc.

Melt Pharmaceuticals, Inc.

Surface Ophthalmics, Inc.

Other

Harrow Health, Inc.

Dennis Elias Saadeh

John P Berdahl

William F Wiley

Mark L Baum

Kamran Hosseini

Thomas E Ichim

Richard L Lindstrom

John Scott Karolchyk

Jeffrey T Liegner

Bernard Covalesky

Richard Dilzer

Annette Marleau

Matthew James Buderer

Kallan Peters

Andrew R Boll

William Wiley

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a β-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Compositions may be incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Pharmaceutical compositions and methods for anesthesiological applications

Pharmaceutical compositions are described, the compositions comprising an immunosuppressant (such as mycophenolic acid) in combination with a very low concentration of a corticosteroid (such as betamethasone) that are capable of treating, preventing, and/or alleviating an ocular surface disease. Methods for fabricating the compositions and using them are also described.

Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease

Pharmaceutical compositions are described, the compositions comprising therapeutically effective quantities of compounds (such as mycophenolic acid or cyclosporine) that are capable of treating, preventing, and/or or alleviating an ocular surface disease. Methods for fabricating the compositions and using them are also described.

Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.

Adrenocorticotropic hormone-based pharmaceutical formulations and methods for fabricating and using thereof

Pharmaceutical compositions that include aqueous suspensions of therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating and using the compositions, and kits that include the compositions are also described.

Pyrimethamine-based pharmaceutical compositions and methods for fabricating thereof

Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating the compositions and using them are also described.

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a &#x3b2;-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Pharmaceutical compositions for treating, mitigating or preventing fungal nail diseases, disorders or pathologies are described, the compositions comprising at least one functionalized allylamine compound, at least one functionalized triazole compound, and at least one functionalized imidazole compound. Methods for fabricating the compositions and using them are also described.

Anti-fungal compositions for treating nails and methods for fabricating and using thereof

The present invention relates to pharmaceutical formulations comprising xanthine or xanthine derivatives, kits thereof, and methods for treating fibrotic diseases by local administration.

Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a &#x3b2;-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a &#x3b2;-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.

Growing community of inventors

Irvine, CA, United States of America

Dennis Elias Saadeh